Organizations:
Algonquin College, BC Cancer, BioCanRx network, Canada Foundation for Innovation, Government of Canada, Mitacs, Ontario Institute for Cancer Research, The Ottawa Hospital, The Ottawa Hospital Foundation, The Ottawa Hospital's Biotherapeutics Manufacturing Centre, and University of Ottawa
People:
Topics:
biologics manufacturing, Canada's biomanufacturing sector, Canadian Partnership for Research in Immunotherapy Manufacturing Excellence, Canadian-Led Immunotherapies in Cancer-01 clinical trial, CAR-T therapies, made-in-Canada immunotherapies, and training in biotherapeutics manufacturing
Canadian manufacturing of CAR-T cells a game-changer for cancer patients and researchers
Leah GellerAugust 10, 2022
A pioneering clinical trial by The Ottawa Hospital is using made-in-Canada genetically engineered T calls, called CART-T cells, to keep cancer patients alive and cancer-free.
Other News
Events For Leaders in
Science, Tech, Innovation, and Policy
Discuss and learn from those in the know at our virtual and in-person events.
See Upcoming Events
You have 0 free articles remaining.
Don't miss out - start your free trial today.
Start your FREE trial Already a member? Log in
By using this website, you agree to our use of cookies. We use cookies to provide you with a great experience and to help our website run effectively in accordance with our Privacy Policy and Terms of Service.